- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↑ 0.42%
NAV chart with SMA (Simple moving average) overlay
SMA (Simple Moving Average)
- 100 SMA
- 200 SMA
- 300 SMA
- 400 SMA
- 500 SMA
Returns
Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
---|---|---|---|---|---|---|---|---|---|---|
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | -5.49% | 0.42% | 1.03% | -0.03% | -0.8% | -2.37% | 20.46% | - | - | - |
Portfolio
Asset allocation
Equity | Debt | Realestate | Commodities | Cash & Equivalents |
---|---|---|---|---|
97.83% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 2.17% |
Equity
Name | Sector | Weight % |
---|---|---|
Sun Pharmaceutical Industries Limited | Pharmaceuticals & Biotechnology | 10.60% |
Divi's Laboratories Limited | Pharmaceuticals & Biotechnology | 8.38% |
Apollo Hospitals Enterprise Limited | Healthcare Services | 5.96% |
Max Healthcare Institute Limited | Healthcare Services | 5.89% |
Torrent Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 4.53% |
Cohance Lifesciences Limited | Pharmaceuticals & Biotechnology | 4.31% |
Fortis Healthcare Limited | Healthcare Services | 3.87% |
Aurobindo Pharma Limited | Pharmaceuticals & Biotechnology | 3.43% |
Aster DM Healthcare Limited | Healthcare Services | 3.30% |
Lupin Limited | Pharmaceuticals & Biotechnology | 3.01% |
Mankind Pharma Limited | Pharmaceuticals & Biotechnology | 2.97% |
Alkem Laboratories Limited | Pharmaceuticals & Biotechnology | 2.91% |
Wockhardt Limited | Pharmaceuticals & Biotechnology | 2.49% |
Neuland Laboratories Limited | Pharmaceuticals & Biotechnology | 2.36% |
Abbott India Limited | Pharmaceuticals & Biotechnology | 2.34% |
Cipla Limited | Pharmaceuticals & Biotechnology | 2.33% |
Dr. Reddy's Laboratories Limited | Pharmaceuticals & Biotechnology | 2.02% |
Healthcare Global Enterprises Limited | Healthcare Services | 1.87% |
Sai Life Sciences Limited | Pharmaceuticals & Biotechnology | 1.65% |
Sumitomo Chemical India Limited | Fertilizers & Agrochemicals | 1.55% |
Vijaya Diagnostic Centre Limited | Healthcare Services | 1.52% |
FDC Limited | Pharmaceuticals & Biotechnology | 1.43% |
Rainbow Childrens Medicare Limited | Healthcare Services | 1.33% |
Laurus Labs Limited | Pharmaceuticals & Biotechnology | 1.33% |
IPCA Laboratories Limited | Pharmaceuticals & Biotechnology | 1.27% |
SBI Life Insurance Company Limited | Insurance | 1.24% |
Orchid Pharma Limited | Pharmaceuticals & Biotechnology | 1.17% |
Standard Glass Lining Technology Ltd | Industrial Manufacturing | 1.05% |
Onesource Specialty Pharma Limited | Pharmaceuticals & Biotechnology | 1.04% |
Sagility India Limited | IT - Services | 1.00% |
GlaxoSmithKline Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 0.97% |
Supriya Lifescience Limited | Pharmaceuticals & Biotechnology | 0.96% |
SRF Limited | Chemicals & Petrochemicals | 0.94% |
Shilpa Medicare Limited | Pharmaceuticals & Biotechnology | 0.92% |
Caplin Point Laboratories Limited | Pharmaceuticals & Biotechnology | 0.91% |
Linde India Limited | Chemicals & Petrochemicals | 0.88% |
Navin Fluorine International Limited | Chemicals & Petrochemicals | 0.82% |
Glenmark Pharmaceuticals Limited | Pharmaceuticals & Biotechnology | 0.78% |
UPL Limited | Fertilizers & Agrochemicals | 0.73% |
Biocon Limited | Pharmaceuticals & Biotechnology | 0.68% |
Zydus Lifesciences Limited | Pharmaceuticals & Biotechnology | 0.62% |
Syngene International Limited | Healthcare Services | 0.47% |
Debt
Name | Rating | Weight % |
---|
Portfolio data is as on date 31 August, 2025
NAV (Net asset value) history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV history
Date | NAV |
---|---|
20 October, 2025 | 16.5704 |
17 October, 2025 | 16.5012 |
16 October, 2025 | 16.4252 |
15 October, 2025 | 16.3245 |
14 October, 2025 | 16.3048 |
13 October, 2025 | 16.4012 |
10 October, 2025 | 16.4180 |
9 October, 2025 | 16.2523 |
8 October, 2025 | 16.1025 |
7 October, 2025 | 16.1355 |
6 October, 2025 | 16.1007 |
3 October, 2025 | 15.9486 |
1 October, 2025 | 15.9622 |
30 September, 2025 | 15.7911 |
29 September, 2025 | 15.8084 |
26 September, 2025 | 15.7412 |
25 September, 2025 | 16.1241 |
24 September, 2025 | 16.2206 |
23 September, 2025 | 16.3314 |
22 September, 2025 | 16.4200 |
19 September, 2025 | 16.5755 |
18 September, 2025 | 16.4949 |
17 September, 2025 | 16.4206 |
16 September, 2025 | 16.4325 |
15 September, 2025 | 16.3947 |
12 September, 2025 | 16.4480 |
11 September, 2025 | 16.4511 |
10 September, 2025 | 16.3960 |
9 September, 2025 | 16.3084 |
8 September, 2025 | 16.2446 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 16.5704 as on 20 October, 2025.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -5.49% as on 20 October, 2025.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are -2.37% as on 20 October, 2025.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 20.46% as on 20 October, 2025.